1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-27.40%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-30.39%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-146.88%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-162.90%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-180.00%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-180.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-180.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.59%
OCF growth above 1.5x 6203.T's 2.04%. David Dodd would confirm a clear edge in underlying cash generation.
9.59%
FCF growth above 1.5x 6203.T's 2.04%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-30.52%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-6.70%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
1.86%
Positive 3Y CAGR while 6203.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-147.74%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-1678.92%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-56.19%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
101.72%
Positive growth while 6203.T is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
48.01%
5Y equity/share CAGR above 1.5x 6203.T's 24.68%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
31.40%
3Y equity/share CAGR above 1.5x 6203.T's 19.70%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
12.82%
Our AR growth while 6203.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
19.48%
Inventory growth well above 6203.T's 11.40%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
13.51%
Positive asset growth while 6203.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-0.62%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
32.76%
Debt growth far above 6203.T's 8.79%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
42.86%
We increase R&D while 6203.T cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-0.46%
We cut SG&A while 6203.T invests at 1.15%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.